Neumora Therapeutics (NMRA) Shares Issued (2022 - 2026)
Neumora Therapeutics (NMRA) posted quarterly Shares Issued of $32.4 million for Q1 2026, up 399.94% year-over-year from $6.5 million in Q1 2025, and up 38.4% quarter-over-quarter from $23.4 million in Q4 2025.
Neumora Therapeutics (NMRA) Shares Issued (2022 - 2026) Analysis & Trends
Neumora Therapeutics' Shares Issued history runs 5 years deep, the most recent figure standing at $32.4 million for Q1 2026.
- In Q1 2026, Shares Issued rose 399.94% year-over-year to $32.4 million; the TTM figure through Mar 2026 stood at $32.4 million (up 399.94% YoY), while the FY2025 annual figure was $23.4 million, up 68.33% from the prior year.
- Shares Issued for Q1 2026 stood at $32.4 million, up from $23.4 million in the prior quarter.
- The five-year high for Shares Issued was $32.4 million in Q1 2026, with the low at $3.0 million in Q3 2023.
- The 5-year median for Shares Issued is $13.9 million (2023), against an average of $13.9 million.
- The sharpest annual moves came in 2025 and 2026: Shares Issued plunged 57.11% in 2025, then jumped 399.94% in 2026.
- Neumora Therapeutics' Shares Issued stood at $8.6 million in 2022, then jumped by 60.83% to $13.8 million in 2023, then rose by 1.04% to $13.9 million in 2024, then surged by 68.33% to $23.4 million in 2025, then soared by 38.4% to $32.4 million in 2026.
- Business Quant data shows NMRA's Shares Issued at $32.4 million in Q1 2026, $23.4 million in Q4 2025, and $23.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Neumora Therapeutics | 296.45 Mn | 296.45 Mn | - | 32.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.45 Mn |
| Mar 31, 2026 | 32.45 Mn |
| Dec 31, 2025 | 23.44 Mn |
| Dec 31, 2025 | 23.44 Mn |
| Sep 30, 2025 | 23.37 Mn |
| Sep 30, 2025 | 23.37 Mn |
| Jun 30, 2025 | 7.22 Mn |
| Jun 30, 2025 | 7.22 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 13.93 Mn |
| Dec 31, 2024 | 13.93 Mn |
| Sep 30, 2024 | 4.69 Mn |
| Sep 30, 2024 | 4.69 Mn |
| Jun 30, 2024 | 14.63 Mn |
| Jun 30, 2024 | 14.63 Mn |
| Mar 31, 2024 | 15.13 Mn |
| Mar 31, 2024 | 15.13 Mn |
| Dec 31, 2023 | 13.78 Mn |
| Dec 31, 2023 | 13.78 Mn |